Multidrug- and Rifampicin-resistant Tuberculosis

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2024-03-15
Clinical Trial Update: BPaL(M) Regimen for the Treatment of MDR/RR-TB [Phase 4]
Phase 4 clinical trial update for the BPaL(M) regimen targeting multidrug- and rifampicin-resistant tuberculosis, currently recruiting.